At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Medtronic Bifurcation Stent Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Medtronic Bare Metal Bifurcation Stent Clinical Trial in Humans
In Brief
A clinical study evaluating Medtronic Bifurcation Stent System for Coronary Artery Disease and Myocardial Ischemia. Completed, enrolled 60 participants across 1 site.
Detailed Summary
To assess the feasibility and safety of the Medtronic Bifurcation Stent System for the treatment of single de novo bifurcation lesions in native coronary arteries with reference vessel diameters (RVD) for the proximal main vessel of 3.8 - 4.3 mm, distal main branch of 3.0 - 3.5 mm, and side branch RVD up to 2.5 mm.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Myocardial Ischemia
CountriesNew Zealand
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedFeb 2008
Primary CompletionAug 2010
TodayJul 2026
First PostedFeb 5, 2008
Enrollment StartFeb 1, 2008
Primary CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 18.4 years ago
Interventions
Medtronic Bifurcation Stent Systemdevice
Percutaneous Coronary Stenting